Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Neurocrine Bioscience | 62 | 0 | 13 | 0 | €129.60 | €160.60 | 23.919% |
| Ionis Pharmaceuticals Inc. | 63 | 1 | 4 | 0 | €48.46 | €79.80 | 64.682% |
| Insulet Corp. | 60 | 1 | 3 | 0 | €128.10 | €304.43 | 137.653% |
| Alnylam Pharmace. | 50 | 0 | 12 | 0 | €196.75 | €426.44 | 116.744% |
| Jazz Pharmaceuticals plc | 50 | 0 | 13 | 0 | €213.10 | €236.55 | 11.004% |
| Tenet Healthcare | 44 | 0 | 11 | 0 | €226.00 | €223.08 | -1.293% |
| Arrowhead Pharmaceuticals Inc. | 30 | 0 | 8 | 0 | €73.34 | €85.20 | 16.164% |
| Acadia Pharmaceuticals | 28 | 0 | 4 | 0 | €24.62 | €29.45 | 19.626% |
| United Therapeutics | 28 | 1 | 2 | 0 | €430.70 | €541.88 | 25.813% |
| Ultragenyx Pharmaceutical Inc. | 26 | 0 | 3 | 0 | €22.77 | €50.06 | 119.863% |
| Charles River Labs Intl | 25 | 0 | 4 | 0 | €243.90 | - | - |
| Halozyme Therapeutics Inc. | 24 | 1 | 4 | 0 | €87.30 | €86.12 | -1.347% |
| Merit Medical Systems | 23 | 0 | 6 | 0 | €78.50 | €88.76 | 13.076% |
| Haemonetics Corp. | 23 | 0 | 4 | 0 | €79.50 | €76.38 | -3.931% |
| Alkermes plc | 23 | 1 | 1 | 0 | €42.58 | €46.86 | 10.054% |
| Repligen Corp. | 21 | 0 | 4 | 0 | €142.80 | €151.15 | 5.848% |
| Agios Pharmaceuticals Inc. | 21 | 0 | 3 | 0 | €29.20 | €35.33 | 20.985% |
| West Pharmaceutical Services Inc. | 21 | 0 | 3 | 0 | €300.20 | €301.42 | 0.406% |
| Bio-Techne Corp. | 18 | 0 | 0 | 0 | €62.50 | €60.82 | -2.683% |
| PTC Therapeutics Inc. | 19 | 1 | 4 | 0 | €62.32 | €79.11 | 26.935% |
| Exelixis Inc. | 17 | 1 | 0 | 0 | €43.90 | €43.76 | -0.300% |
| Xencor Inc. | 15 | 1 | 3 | 0 | €19.80 | €22.84 | 15.377% |
| Icon plc | 15 | 2 | 2 | 0 | €143.55 | €165.33 | 15.170% |
| Bruker Corp. | 14 | 1 | 0 | 0 | €51.45 | €51.79 | 0.659% |
| LivaNova plc | 13 | 0 | 1 | 0 | €71.50 | €72.85 | 1.891% |